Hakim Nasrat A 13D and 13G filings for Elite Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-09-01 4:04 pm Purchase |
2020-08-24 | 13D | Elite Pharmaceuticals, Inc. ELTP |
Hakim Nasrat A | 267,272,787 24.200% |
267,272,787 (New Position) |
Filing |